Skip to content

Effect of Chlorhexidine Skin Cleansing on Skin Flora

Effect of Chlorhexidine Skin Cleansing on Skin Flora of Newborn Infants in Bangladesh

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00198679
Enrollment
210
Registered
2005-09-20
Start date
2004-03-31
Completion date
2005-03-31
Last updated
2018-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Diseases, Infectious

Keywords

skin cleansing, Bangladesh, Skin Flora, Newborn, infectious disease, chlorhexidine

Brief summary

Given the potential of skin cleansing with chlorhexidine as a safe, feasible, and cost-effective intervention for reducing neonatal death in developing country settings, this study follows a trial already underway in Nepal to test the impact of a single cleansing of the skin with baby wipes cotaining chlorahexidine.

Detailed description

This study is designed to test the impact of a single cleansing of the skin with 0.25% or 4.0% Chlorhexidine wipes on qualitative and quantitative skin flora and skin condition in newborn infants. The study takes place in the Special Care Nursery at Dhaka Shishu Hospital in Dhaka, Bangladesh.

Interventions

DRUGChlorhexidine

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 48 Hours
Healthy volunteers
Yes

Inclusion criteria

* Infant admitted to Special Care Nursery at Dhaka Shishu Hospital less than 48 hours chronological age * parental consent must be obtained

Exclusion criteria

* infants being admitted for major surgical procedure which is attended by high rate of infectious complications * sepsis * clinically-evident skin infection * generalized skin disease * structural defect of the skin involving greater than 5% of the body surface * with a major congenital anomaly * with a known immunodeficiency

Design outcomes

Primary

MeasureTime frame
Wiping of newborn skin will be done immediatly upon enrollment in study, with follow up during hosptial stay and up to two weeks to determine skin condition and presence of any kind of skin infection.

Countries

Bangladesh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026